Evidence map›Paper›PMID 39767661›Full record

ArticleBiomedicines2024

Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery.

Caroline Truntzer, Dina Ouahbi, Titouan Huppé, David Rageot, Alis Ilie, Chloe Molimard, Françoise Beltjens, Anthony Bergeron, Angelique Vienot, Christophe Borg and 4 more

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Caroline TruntzerCancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.ORCID 0000-0003-0895-4813
Dina OuahbiCancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.ORCID 0009-0008-2094-7425
Titouan HuppéCancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.
David RageotCancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.
Alis IlieCancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.
Chloe MolimardDepartment of Pathology, CHU Besançon, F-25000 Besançon, France.
Françoise BeltjensDepartment of Pathology, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.
Anthony BergeronDepartment of Pathology, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.
Angelique VienotDepartment of Medical Oncology, CHU Besançon, F-25000 Besançon, France.ORCID 0000-0002-0381-7601
Christophe BorgDepartment of Medical Oncology, CHU Besançon, F-25000 Besançon, France.
Franck MonnienDepartment of Pathology, CHU Besançon, F-25000 Besançon, France.ORCID 0000-0002-2799-3730
Frédéric BibeauDepartment of Pathology, CHU Besançon, F-25000 Besançon, France.
Valentin DerangèreCancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.
François GhiringhelliCancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.ORCID 0000-0002-5465-8305

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerdeep learningpancreatic cancerprognostic

Identifiers

PMID39767661
PMCPMC11673784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.